de Jong WK - Search Results

1

Irinotecan and cisplatin with concurrent thoracic radiotherapy in a once-every-three-weeks schedule in patients with limited-disease small-cell lung cancer: a phase I study.

de Jong WK, de Jonge MJ, van der Leest AH, van Meerbeeck JP, Groen HJ. de Jong WK, et al. Among authors: de jonge mj. Lung Cancer. 2008 Jul;61(1):123-8. doi: 10.1016/j.lungcan.2007.11.010. Epub 2008 Jan 7. Lung Cancer. 2008. PMID: 18179842 Clinical Trial.

2

A 20-year-old male with thoracic pain and a lower thoracic mass. Diagnosis: intrathoracal desmoid tumour with microscopically incomplete resection.

de Jong WK, van der Graaf WT, van der Jagt EJ, Klinkenberg TJ, Groen HJ, Timens W, Douma WR. de Jong WK, et al. Eur Respir J. 2005 Oct;26(4):740-3. doi: 10.1183/09031936.05.00051605. Eur Respir J. 2005. PMID: 16204607 Free article. No abstract available.

3

Third-line chemotherapy for small cell lung cancer.

de Jong WK, ten Hacken NH, Groen HJ. de Jong WK, et al. Lung Cancer. 2006 Jun;52(3):339-42. doi: 10.1016/j.lungcan.2006.02.005. Epub 2006 Mar 24. Lung Cancer. 2006. PMID: 16564112

4

Prognostic classification with laboratory parameters or imaging techniques in small-cell lung cancer.

de Jong WK, Fidler V, Groen HJ. de Jong WK, et al. Clin Lung Cancer. 2007 May;8(6):376-81. doi: 10.3816/CLC.2007.n.018. Clin Lung Cancer. 2007. PMID: 17562238

5

Phase III study of cyclophosphamide, doxorubicin, and etoposide compared with carboplatin and paclitaxel in patients with extensive disease small-cell lung cancer.

de Jong WK, Groen HJ, Koolen MG, Biesma B, Willems LN, Kwa HB, van Bochove A, van Tinteren H, Smit EF. de Jong WK, et al. Eur J Cancer. 2007 Nov;43(16):2345-50. doi: 10.1016/j.ejca.2007.07.029. Epub 2007 Sep 10. Eur J Cancer. 2007. PMID: 17826977 Clinical Trial.

6

Prognostic value of different metabolic measurements with fluorine-18 fluorodeoxyglucose positron emission tomography in resectable non-small cell lung cancer: a two-center study.

de Jong WK, van der Heijden HF, Pruim J, Dalesio O, Oyen WJ, Groen HJ. de Jong WK, et al. J Thorac Oncol. 2007 Nov;2(11):1007-12. doi: 10.1097/JTO.0b013e31815608f5. J Thorac Oncol. 2007. PMID: 17975491 Free article.

7

Thymic epithelial tumours: a population-based study of the incidence, diagnostic procedures and therapy.

de Jong WK, Blaauwgeers JL, Schaapveld M, Timens W, Klinkenberg TJ, Groen HJ. de Jong WK, et al. Eur J Cancer. 2008 Jan;44(1):123-30. doi: 10.1016/j.ejca.2007.11.004. Eur J Cancer. 2008. PMID: 18068351

8

Pulmonary tumours in the Netherlands: focus on temporal trends in histology and stage and on rare tumours.

de Jong WK, Schaapveld M, Blaauwgeers JL, Groen HJ. de Jong WK, et al. Thorax. 2008 Dec;63(12):1096-102. doi: 10.1136/thx.2007.095067. Epub 2008 Aug 4. Thorax. 2008. PMID: 18678702

9

Promoter methylation primarily occurs in tumor cells of patients with non-small cell lung cancer.

De Jong WK, Verpooten GF, Kramer H, Louwagie J, Groen HJ. De Jong WK, et al. Anticancer Res. 2009 Jan;29(1):363-9. Anticancer Res. 2009. PMID: 19331174 Free article.

10

Current smoking-specific gene expression signature in normal bronchial epithelium is enhanced in squamous cell lung cancer.

Boelens MC, van den Berg A, Fehrmann RS, Geerlings M, de Jong WK, te Meerman GJ, Sietsma H, Timens W, Postma DS, Groen HJ. Boelens MC, et al. Among authors: de jong wk. J Pathol. 2009 Jun;218(2):182-91. doi: 10.1002/path.2520. J Pathol. 2009. PMID: 19334046

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters